We also observed that treating KCs with DMBT1-overexpressing tumor CM enhanced MUC1-C nuclear localization and NF-κB activation, while the CM of cancer cells with DMBT1 knockdown had the opposite effects (Fig. 7b). The gene discussed is DMBT1; the disease is neoplasm.